TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Biological Drug CDMO Market Research Report 2024-2030 (Status and Outlook)

Global Biological Drug CDMO Market Research Report 2024-2030 (Status and Outlook)

  • Category:Life Sciences
  • Published on : 08 May 2024
  • Pages :136
  • Formats:
  • Report Code:SMR-7941574
OfferClick for best price

Best Price: $2600

Biological Drug CDMO Market Size, Share 2024


Report Overview

Biological drug CDMO (Contract Development and Manufacturing Organization) is a company that specializes in the development and manufacturing of biological drugs. Biological drugs are complex molecules that are produced from living cells, and they include a wide range of products such as vaccines, monoclonal antibodies, and cell therapies.

This report provides a deep insight into the global Biological Drug CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biological Drug CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biological Drug CDMO market in any manner.

Global Biological Drug CDMO Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Samsung Biologics

Lonza

Boehringer Ingelheim

Catalent

BioCentriq

FUJIFILM Diosynth Biotechnologies

Thermo Fisher Scientific

Recipharm

Delpharm

Aenova

Siegfried

WuXi Biologics

Obio Technology

Hepalink

Pharmaron

ChemPartner

Market Segmentation (by Type)

Innovative Drug

Listed Patent Drugs

Biosimilar

Market Segmentation (by Application)

Pharmaceutical Company

Biotechnology Company

Geographic Segmentation

? North America (USA, Canada, Mexico)

? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

? South America (Brazil, Argentina, Columbia, Rest of South America)

? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

? Industry drivers, restraints, and opportunities covered in the study

? Neutral perspective on the market performance

? Recent industry trends and developments

? Competitive landscape & strategies of key players

? Potential & niche segments and regions exhibiting promising growth covered

? Historical, current, and projected market size, in terms of value

? In-depth analysis of the Biological Drug CDMO Market

? Overview of the regional outlook of the Biological Drug CDMO Market:

Key Reasons to Buy this Report:

? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

? This enables you to anticipate market changes to remain ahead of your competitors

? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

? Provision of market value (USD Billion) data for each segment and sub-segment

? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis

? Provides insight into the market through Value Chain

? Market dynamics scenario, along with growth opportunities of the market in the years to come

? 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biological Drug CDMO Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Report Attributes Report Details
Report Title Global Biological Drug CDMO Market Research Report 2024-2030 (Status and Outlook)
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2023
Forecast Year 2031
Number of Pages 136 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Biological Drug CDMO
1.2 Key Market Segments
1.2.1 Biological Drug CDMO Segment by Type
1.2.2 Biological Drug CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Biological Drug CDMO Market Overview
2.1 Global Market Overview
2.1.1 Global Biological Drug CDMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biological Drug CDMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Biological Drug CDMO Market Competitive Landscape
3.1 Global Biological Drug CDMO Sales by Manufacturers (2019-2024)
3.2 Global Biological Drug CDMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Biological Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biological Drug CDMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biological Drug CDMO Sales Sites, Area Served, Product Type
3.6 Biological Drug CDMO Market Competitive Situation and Trends
3.6.1 Biological Drug CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biological Drug CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Biological Drug CDMO Industry Chain Analysis
4.1 Biological Drug CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Biological Drug CDMO Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Biological Drug CDMO Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biological Drug CDMO Sales Market Share by Type (2019-2024)
6.3 Global Biological Drug CDMO Market Size Market Share by Type (2019-2024)
6.4 Global Biological Drug CDMO Price by Type (2019-2024)
7 Biological Drug CDMO Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biological Drug CDMO Market Sales by Application (2019-2024)
7.3 Global Biological Drug CDMO Market Size (M USD) by Application (2019-2024)
7.4 Global Biological Drug CDMO Sales Growth Rate by Application (2019-2024)
8 Biological Drug CDMO Market Segmentation by Region
8.1 Global Biological Drug CDMO Sales by Region
8.1.1 Global Biological Drug CDMO Sales by Region
8.1.2 Global Biological Drug CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Biological Drug CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biological Drug CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biological Drug CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biological Drug CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biological Drug CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Samsung Biologics
9.1.1 Samsung Biologics Biological Drug CDMO Basic Information
9.1.2 Samsung Biologics Biological Drug CDMO Product Overview
9.1.3 Samsung Biologics Biological Drug CDMO Product Market Performance
9.1.4 Samsung Biologics Business Overview
9.1.5 Samsung Biologics Biological Drug CDMO SWOT Analysis
9.1.6 Samsung Biologics Recent Developments
9.2 Lonza
9.2.1 Lonza Biological Drug CDMO Basic Information
9.2.2 Lonza Biological Drug CDMO Product Overview
9.2.3 Lonza Biological Drug CDMO Product Market Performance
9.2.4 Lonza Business Overview
9.2.5 Lonza Biological Drug CDMO SWOT Analysis
9.2.6 Lonza Recent Developments
9.3 Boehringer Ingelheim
9.3.1 Boehringer Ingelheim Biological Drug CDMO Basic Information
9.3.2 Boehringer Ingelheim Biological Drug CDMO Product Overview
9.3.3 Boehringer Ingelheim Biological Drug CDMO Product Market Performance
9.3.4 Boehringer Ingelheim Biological Drug CDMO SWOT Analysis
9.3.5 Boehringer Ingelheim Business Overview
9.3.6 Boehringer Ingelheim Recent Developments
9.4 Catalent
9.4.1 Catalent Biological Drug CDMO Basic Information
9.4.2 Catalent Biological Drug CDMO Product Overview
9.4.3 Catalent Biological Drug CDMO Product Market Performance
9.4.4 Catalent Business Overview
9.4.5 Catalent Recent Developments
9.5 BioCentriq
9.5.1 BioCentriq Biological Drug CDMO Basic Information
9.5.2 BioCentriq Biological Drug CDMO Product Overview
9.5.3 BioCentriq Biological Drug CDMO Product Market Performance
9.5.4 BioCentriq Business Overview
9.5.5 BioCentriq Recent Developments
9.6 FUJIFILM Diosynth Biotechnologies
9.6.1 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Basic Information
9.6.2 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Product Overview
9.6.3 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Product Market Performance
9.6.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.7 Thermo Fisher Scientific
9.7.1 Thermo Fisher Scientific Biological Drug CDMO Basic Information
9.7.2 Thermo Fisher Scientific Biological Drug CDMO Product Overview
9.7.3 Thermo Fisher Scientific Biological Drug CDMO Product Market Performance
9.7.4 Thermo Fisher Scientific Business Overview
9.7.5 Thermo Fisher Scientific Recent Developments
9.8 Recipharm
9.8.1 Recipharm Biological Drug CDMO Basic Information
9.8.2 Recipharm Biological Drug CDMO Product Overview
9.8.3 Recipharm Biological Drug CDMO Product Market Performance
9.8.4 Recipharm Business Overview
9.8.5 Recipharm Recent Developments
9.9 Delpharm
9.9.1 Delpharm Biological Drug CDMO Basic Information
9.9.2 Delpharm Biological Drug CDMO Product Overview
9.9.3 Delpharm Biological Drug CDMO Product Market Performance
9.9.4 Delpharm Business Overview
9.9.5 Delpharm Recent Developments
9.10 Aenova
9.10.1 Aenova Biological Drug CDMO Basic Information
9.10.2 Aenova Biological Drug CDMO Product Overview
9.10.3 Aenova Biological Drug CDMO Product Market Performance
9.10.4 Aenova Business Overview
9.10.5 Aenova Recent Developments
9.11 Siegfried
9.11.1 Siegfried Biological Drug CDMO Basic Information
9.11.2 Siegfried Biological Drug CDMO Product Overview
9.11.3 Siegfried Biological Drug CDMO Product Market Performance
9.11.4 Siegfried Business Overview
9.11.5 Siegfried Recent Developments
9.12 WuXi Biologics
9.12.1 WuXi Biologics Biological Drug CDMO Basic Information
9.12.2 WuXi Biologics Biological Drug CDMO Product Overview
9.12.3 WuXi Biologics Biological Drug CDMO Product Market Performance
9.12.4 WuXi Biologics Business Overview
9.12.5 WuXi Biologics Recent Developments
9.13 Obio Technology
9.13.1 Obio Technology Biological Drug CDMO Basic Information
9.13.2 Obio Technology Biological Drug CDMO Product Overview
9.13.3 Obio Technology Biological Drug CDMO Product Market Performance
9.13.4 Obio Technology Business Overview
9.13.5 Obio Technology Recent Developments
9.14 Hepalink
9.14.1 Hepalink Biological Drug CDMO Basic Information
9.14.2 Hepalink Biological Drug CDMO Product Overview
9.14.3 Hepalink Biological Drug CDMO Product Market Performance
9.14.4 Hepalink Business Overview
9.14.5 Hepalink Recent Developments
9.15 Pharmaron
9.15.1 Pharmaron Biological Drug CDMO Basic Information
9.15.2 Pharmaron Biological Drug CDMO Product Overview
9.15.3 Pharmaron Biological Drug CDMO Product Market Performance
9.15.4 Pharmaron Business Overview
9.15.5 Pharmaron Recent Developments
9.16 ChemPartner
9.16.1 ChemPartner Biological Drug CDMO Basic Information
9.16.2 ChemPartner Biological Drug CDMO Product Overview
9.16.3 ChemPartner Biological Drug CDMO Product Market Performance
9.16.4 ChemPartner Business Overview
9.16.5 ChemPartner Recent Developments
10 Biological Drug CDMO Market Forecast by Region
10.1 Global Biological Drug CDMO Market Size Forecast
10.2 Global Biological Drug CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biological Drug CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Biological Drug CDMO Market Size Forecast by Region
10.2.4 South America Biological Drug CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biological Drug CDMO by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Biological Drug CDMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biological Drug CDMO by Type (2025-2030)
11.1.2 Global Biological Drug CDMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biological Drug CDMO by Type (2025-2030)
11.2 Global Biological Drug CDMO Market Forecast by Application (2025-2030)
11.2.1 Global Biological Drug CDMO Sales (K Units) Forecast by Application
11.2.2 Global Biological Drug CDMO Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biological Drug CDMO Market Size Comparison by Region (M USD)
Table 5. Global Biological Drug CDMO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Biological Drug CDMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biological Drug CDMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biological Drug CDMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Drug CDMO as of 2022)
Table 10. Global Market Biological Drug CDMO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biological Drug CDMO Sales Sites and Area Served
Table 12. Manufacturers Biological Drug CDMO Product Type
Table 13. Global Biological Drug CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biological Drug CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biological Drug CDMO Market Challenges
Table 22. Global Biological Drug CDMO Sales by Type (K Units)
Table 23. Global Biological Drug CDMO Market Size by Type (M USD)
Table 24. Global Biological Drug CDMO Sales (K Units) by Type (2019-2024)
Table 25. Global Biological Drug CDMO Sales Market Share by Type (2019-2024)
Table 26. Global Biological Drug CDMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Biological Drug CDMO Market Size Share by Type (2019-2024)
Table 28. Global Biological Drug CDMO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Biological Drug CDMO Sales (K Units) by Application
Table 30. Global Biological Drug CDMO Market Size by Application
Table 31. Global Biological Drug CDMO Sales by Application (2019-2024) & (K Units)
Table 32. Global Biological Drug CDMO Sales Market Share by Application (2019-2024)
Table 33. Global Biological Drug CDMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Biological Drug CDMO Market Share by Application (2019-2024)
Table 35. Global Biological Drug CDMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Biological Drug CDMO Sales by Region (2019-2024) & (K Units)
Table 37. Global Biological Drug CDMO Sales Market Share by Region (2019-2024)
Table 38. North America Biological Drug CDMO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Biological Drug CDMO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Biological Drug CDMO Sales by Region (2019-2024) & (K Units)
Table 41. South America Biological Drug CDMO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Biological Drug CDMO Sales by Region (2019-2024) & (K Units)
Table 43. Samsung Biologics Biological Drug CDMO Basic Information
Table 44. Samsung Biologics Biological Drug CDMO Product Overview
Table 45. Samsung Biologics Biological Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Samsung Biologics Business Overview
Table 47. Samsung Biologics Biological Drug CDMO SWOT Analysis
Table 48. Samsung Biologics Recent Developments
Table 49. Lonza Biological Drug CDMO Basic Information
Table 50. Lonza Biological Drug CDMO Product Overview
Table 51. Lonza Biological Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Lonza Business Overview
Table 53. Lonza Biological Drug CDMO SWOT Analysis
Table 54. Lonza Recent Developments
Table 55. Boehringer Ingelheim Biological Drug CDMO Basic Information
Table 56. Boehringer Ingelheim Biological Drug CDMO Product Overview
Table 57. Boehringer Ingelheim Biological Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Boehringer Ingelheim Biological Drug CDMO SWOT Analysis
Table 59. Boehringer Ingelheim Business Overview
Table 60. Boehringer Ingelheim Recent Developments
Table 61. Catalent Biological Drug CDMO Basic Information
Table 62. Catalent Biological Drug CDMO Product Overview
Table 63. Catalent Biological Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Catalent Business Overview
Table 65. Catalent Recent Developments
Table 66. BioCentriq Biological Drug CDMO Basic Information
Table 67. BioCentriq Biological Drug CDMO Product Overview
Table 68. BioCentriq Biological Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. BioCentriq Business Overview
Table 70. BioCentriq Recent Developments
Table 71. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Basic Information
Table 72. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Product Overview
Table 73. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. FUJIFILM Diosynth Biotechnologies Business Overview
Table 75. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 76. Thermo Fisher Scientific Biological Drug CDMO Basic Information
Table 77. Thermo Fisher Scientific Biological Drug CDMO Product Overview
Table 78. Thermo Fisher Scientific Biological Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Thermo Fisher Scientific Business Overview
Table 80. Thermo Fisher Scientific Recent Developments
Table 81. Recipharm Biological Drug CDMO Basic Information
Table 82. Recipharm Biological Drug CDMO Product Overview
Table 83. Recipharm Biological Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Recipharm Business Overview
Table 85. Recipharm Recent Developments
Table 86. Delpharm Biological Drug CDMO Basic Information
Table 87. Delpharm Biological Drug CDMO Product Overview
Table 88. Delpharm Biological Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Delpharm Business Overview
Table 90. Delpharm Recent Developments
Table 91. Aenova Biological Drug CDMO Basic Information
Table 92. Aenova Biological Drug CDMO Product Overview
Table 93. Aenova Biological Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Aenova Business Overview
Table 95. Aenova Recent Developments
Table 96. Siegfried Biological Drug CDMO Basic Information
Table 97. Siegfried Biological Drug CDMO Product Overview
Table 98. Siegfried Biological Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Siegfried Business Overview
Table 100. Siegfried Recent Developments
Table 101. WuXi Biologics Biological Drug CDMO Basic Information
Table 102. WuXi Biologics Biological Drug CDMO Product Overview
Table 103. WuXi Biologics Biological Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. WuXi Biologics Business Overview
Table 105. WuXi Biologics Recent Developments
Table 106. Obio Technology Biological Drug CDMO Basic Information
Table 107. Obio Technology Biological Drug CDMO Product Overview
Table 108. Obio Technology Biological Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Obio Technology Business Overview
Table 110. Obio Technology Recent Developments
Table 111. Hepalink Biological Drug CDMO Basic Information
Table 112. Hepalink Biological Drug CDMO Product Overview
Table 113. Hepalink Biological Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Hepalink Business Overview
Table 115. Hepalink Recent Developments
Table 116. Pharmaron Biological Drug CDMO Basic Information
Table 117. Pharmaron Biological Drug CDMO Product Overview
Table 118. Pharmaron Biological Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Pharmaron Business Overview
Table 120. Pharmaron Recent Developments
Table 121. ChemPartner Biological Drug CDMO Basic Information
Table 122. ChemPartner Biological Drug CDMO Product Overview
Table 123. ChemPartner Biological Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. ChemPartner Business Overview
Table 125. ChemPartner Recent Developments
Table 126. Global Biological Drug CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 127. Global Biological Drug CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Biological Drug CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 129. North America Biological Drug CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Biological Drug CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 131. Europe Biological Drug CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Biological Drug CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 133. Asia Pacific Biological Drug CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Biological Drug CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 135. South America Biological Drug CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Biological Drug CDMO Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Biological Drug CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Biological Drug CDMO Sales Forecast by Type (2025-2030) & (K Units)
Table 139. Global Biological Drug CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Biological Drug CDMO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 141. Global Biological Drug CDMO Sales (K Units) Forecast by Application (2025-2030)
Table 142. Global Biological Drug CDMO Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Biological Drug CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biological Drug CDMO Market Size (M USD), 2019-2030
Figure 5. Global Biological Drug CDMO Market Size (M USD) (2019-2030)
Figure 6. Global Biological Drug CDMO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biological Drug CDMO Market Size by Country (M USD)
Figure 11. Biological Drug CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Biological Drug CDMO Revenue Share by Manufacturers in 2023
Figure 13. Biological Drug CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biological Drug CDMO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biological Drug CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biological Drug CDMO Market Share by Type
Figure 18. Sales Market Share of Biological Drug CDMO by Type (2019-2024)
Figure 19. Sales Market Share of Biological Drug CDMO by Type in 2023
Figure 20. Market Size Share of Biological Drug CDMO by Type (2019-2024)
Figure 21. Market Size Market Share of Biological Drug CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biological Drug CDMO Market Share by Application
Figure 24. Global Biological Drug CDMO Sales Market Share by Application (2019-2024)
Figure 25. Global Biological Drug CDMO Sales Market Share by Application in 2023
Figure 26. Global Biological Drug CDMO Market Share by Application (2019-2024)
Figure 27. Global Biological Drug CDMO Market Share by Application in 2023
Figure 28. Global Biological Drug CDMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biological Drug CDMO Sales Market Share by Region (2019-2024)
Figure 30. North America Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Biological Drug CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Biological Drug CDMO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Biological Drug CDMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Biological Drug CDMO Sales Market Share by Country in 2023
Figure 37. Germany Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Biological Drug CDMO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biological Drug CDMO Sales Market Share by Region in 2023
Figure 44. China Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Biological Drug CDMO Sales and Growth Rate (K Units)
Figure 50. South America Biological Drug CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Biological Drug CDMO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biological Drug CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Biological Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Biological Drug CDMO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Biological Drug CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biological Drug CDMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biological Drug CDMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Biological Drug CDMO Sales Forecast by Application (2025-2030)
Figure 66. Global Biological Drug CDMO Market Share Forecast by Application (2025-2030)

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount